Loading page content…
Loading page content…
Loading contract search results…
Loading contract details…
| Source: | Contracts Finder |
| Notice Type: | Award notice |
| Buyer: | NHS england |
| Main Category: | Goods |
| Procurement Method: | Open procedure (above threshold) |
| Tender Status: | Closed |
Pipeline status
Not addedImports the contract into your BidWriter pipeline · Qualify before you commit to bid
Application Deadline
21 February 2023
Closed
Estimated Value
£27,009,807
Need help writing this bid?
Our specialists write winning tender responses. Free consultation, no obligation.
Book a free consultation →| Estimated Value (ex. VAT): |
| £27,009,807 |
| Release Date: | 27 April 2023 |
| Application Deadline: | 21 February 2023 |
| Contract Start Date: | 30 April 2023 |
| Contract End Date: | 31 January 2025 |
| Contract Duration: | 1.8 years |
| Procurement ID (OCID): | ocds-b5fd17-c5f1ad7d-fcac-4ac7-bdd9-f6fe1f150616 |
| Notice Reference: | 101ad108-6a5b-410d-b375-4ca49a187c9e-640340 |
View Original Notice
Access the full notice on the official portal
Awarded to (5 suppliers)
| Award value: | £27,009,807 |
| Award decision date: | 27 March 2023 |
| Award status: | Active |
Invitation to offer for NHS National Generic Pharmaceuticals - Dasatinib and Paliperidone Injection Offer reference number: CM/PHG/22/5694 FIND A TENDER (FTS) - 2023/S 000-001392 Period of framework agreement: The total maximum duration of the framework agreement to be no more than 21 months with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 48 months. Potential periods of call-offs under the framework agreement: CM/PHG/22/5694/00 - Dasatinib CESW 01/05/2023 - 30/04/2024 - (12 Months) LSNE 01/05/2023 - 30/04/2024 - (12 Months) NWLN 01/05/2023 - 30/04/2024 - (12 Months) CM/PHG/22/5694/01 - Paliperidone Injection: LSNE 01/05/2023 - 31/05/2024 (13 Months) NWLN 01/05/2023 - 31/01/2025 (21 months)